Evidence map›Paper›PMID 40192958›Full record

ArticleInfection2025

Mycobacterium chelonae infection of a cardiovascular bioprosthesis linked to a recent outbreak.

Johanna Kessel, Axel Braner, Margo Diricks, Thomas Walther, Tomas Holubec, Rudolf Werner, Michael Hogardt, Thomas A Wichelhaus, Stefan Niemann, Annette Moter and 2 more

Abstract readCase Reports
In one paragraph

Article in Infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Johanna KesselDepartment of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
Axel BranerMVZ Aschaffenburg, Aschaffenburg, Germany.
Margo DiricksMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Thomas WaltherDepartment of Cardiovascular Surgery, University Cardiovascular Center Frankfurt am Main, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
Tomas HolubecDepartment of Cardiovascular Surgery, University Cardiovascular Center Frankfurt am Main, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
Rudolf WernerDepartment of Nuclear Medicine, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
Michael HogardtUniversity Center of Infectious Diseases, UCI, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
Thomas A WichelhausUniversity Center of Infectious Diseases, UCI, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
Stefan NiemannMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Annette MoterBiofilmcenter, Institute for Microbiology, Infectious Diseases, and Immunology, Charité - University Medicine Berlin and MoKi Analytics GmbH, Berlin, Germany.
Inna FriesenNational and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany.
Nils WetzsteinDepartment of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany. wetzstein@med.uni-frankfurt.de.ORCID http://orcid.org/0000-0002-5589-4668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMycobacterium chelonae is a rapid-growing non-tuberculous mycobacterium that has occasionally been described in connection with foreign material infections, e.g. after orthopaedic joint replacement or cosmetic surgery. In a recent outbreak, several cases of M. chelonae endocarditis associated with biological heart valve prostheses were reported. CASE HISTORY: A 64-year-old female patient with a history of myalgia and recurrent joint swelling presented to our hospital. Initially suspected for rheumatoid arthritis, the patient underwent a series of orthopedic and rheumatologic treatments, including prednisolone and methotrexate. Subsequent history revealed a Ross operation in 2014 and a PET-CT was suspicious of a biological valved conduit infection leading to surgical replacement. Utilizing fluorescence in situ hybridization (FISH) diagnostic techniques, DAPI, Kinyoun and Ziehl-Neelsen staining, mycobacterial infection was confirmed in both the prosthesis and adjacent muscle tissue. Molecular methods identified a mycobacterium most closely related to the M. chelonae/abscessus complex indicating an association to a previously described outbreak of M. chelonae contaminated heart valves. Antimycobacterial therapy was initiated and the patient remains stable at the time of writing. To date, all mycobacterial cultures remained negative.

conclusionsNon-tuberculous mycobacteria (NTM) are rare and possibly underdiagnosed pathogens in infections of bioprosthetic flap bearing conduits. Mycobacterial foreign-body infections can manifest many years after implantation. As NTM can be difficult to detect, molecular identification methods are of particular importance. Here, modern imaging, molecular and microscopic techniques might be of special use in diagnosing prolonged prosthetic graft infections.

Indexed as

BioprosthesisDisease OutbreaksHeart Valve ProsthesisMycobacterium chelonaeMycobacterium Infections, NontuberculousProsthesis-Related InfectionsAnti-Bacterial AgentsFemaleHumansMiddle AgedAnti-Bacterial AgentsBioIntegralBioprosthetic valve bearing conduitCardiac surgeryEndocarditisMycobacterial infectionMycobacterium chelonaeNon-tuberculous mycobacteriaNTM

Identifiers

PMID40192958
PMCPMC12316769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.